Prevention and Screening for Early Detection of HPV-related Cancers in Gay and Bisexual Men in Tanzania
1 other identifier
interventional
83
1 country
1
Brief Summary
The long-term objective of the parent study is "to reduce the effects of OPCa through secondary prevention (i.e., early detection, diagnosis and treatment referral)." Consistent with this, this supplement will test HPV-related interventions tailored for Sexual Minority Men (SMM). Acceptability, feasibility and preliminary effectiveness of a smart-phone delivered Oropharyngeal Cancer (OPCA) self-assessment tool will be assessed. Given that homosexuality is stigmatized and criminalized in Tanzania, and that cell phone use is the key way SMM communicate in Tanzania, a self-assessment screening cell phone intervention holds particular promise for SMM in Tanzania but warrants separate evaluation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 28, 2022
CompletedFirst Posted
Study publicly available on registry
November 15, 2022
CompletedStudy Start
First participant enrolled
November 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 25, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 25, 2023
CompletedDecember 14, 2023
December 1, 2023
5 months
October 28, 2022
December 13, 2023
Conditions
Outcome Measures
Primary Outcomes (5)
assess screening practices of hrHPV-related OPCa
Questionaire
Baseline
To assess the acceptability and feasibility of teaching SMM in Tanzania to conduct self-exams
Questionaire to assess post-test selfie evaluations, Scores: 0= was not trained; 1= was trained; 2=took a selfie; 3= clear selfie
baseline to 6 months
To assess the acceptability and feasibility of hrHPV vaccination
percentage of individuals recruited for aim 1 who request HPV vaccination, Scores are 0=no vaccination; 1=first vaccination; 2= second vaccination; 3=third vaccination
baseline
To assess the acceptability and feasibility of hrHPV vaccination
percentage of individuals recruited for aim 1 who request HPV vaccination, Scores are 0=no vaccination; 1=first vaccination; 2= second vaccination; 3=third vaccination
1 month
To assess the acceptability and feasibility of hrHPV vaccination
percentage of individuals recruited for aim 1 who request HPV vaccination, Scores are 0=no vaccination; 1=first vaccination; 2= second vaccination; 3=third vaccination
6 months
Study Arms (1)
Training on self-screening and HPV vaccination administration
EXPERIMENTALteaching SMM in Tanzania to conduct self-exams for oropharyngeal hrHPV-associated cancers using cellphone-mediated oral selfies, and administering the HPV vaccination series (with 2 and 6-8 month follow-up) to those who request it
Interventions
Participants will be taught how to do self-screening for HPV-associated cancers using Training on self-screening and HPV vaccination administration. They will also be given HPV vaccination series.
Eligibility Criteria
You may qualify if:
- Age over 18
- gay or bisexual men
- speak Kiswahili or English
- resident in Dar es Salam
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dar es Salaam
Dar es Salaam, Tanzania
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 28, 2022
First Posted
November 15, 2022
Study Start
November 30, 2022
Primary Completion
April 25, 2023
Study Completion
April 25, 2023
Last Updated
December 14, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share